These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14599943)

  • 1. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):374-82. PubMed ID: 14599943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK; Kittlesen DJ; Hahn YS
    J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
    Alvarez-Lajonchere L; Amador-Cañizares Y; Frías R; Milian Y; Musacchio A; Guerra I; Acosta-Rivero N; Martínez G; Castro J; Puentes P; Cosme K; Dueñas-Carrera S
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):97-105. PubMed ID: 18215116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
    Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
    J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of hepatitis C viral structure protein by recombinant vaccinia virus].
    Wang X; Tan W; Cong X; Guo K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):340-3. PubMed ID: 15617243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
    Grunhaus A; Cho S; Horwitz MS
    Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
    Coupar BE; Andrew ME; Both GW; Boyle DB
    Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core and E2 protein expression in transgenic mice.
    Pasquinelli C; Shoenberger JM; Chung J; Chang KM; Guidotti LG; Selby M; Berger K; Lesniewski R; Houghton M; Chisari FV
    Hepatology; 1997 Mar; 25(3):719-27. PubMed ID: 9049225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice.
    Alvarez-Lajonchere L; González M; Alvarez-Obregón JC; Guerra I; Viña A; Acosta-Rivero N; Musacchio A; Morales J; Dueñas-Carrera S
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):9-17. PubMed ID: 16367740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.